<div class=”container”>

<a href=”http://www.compbio.com/wp-content/uploads/2018/02/broncho_D.png”><img class=”alignleft size-full wp-image-3742″ src=”http://www.compbio.com/wp-content/uploads/2018/02/broncho_D.png” alt=””/></a>
<div class=”centered”>CBI Congratulates <br>Meridigen Biotech Co. Ltd<br>on their successful IND submission<br>for their project:<br><br>

UMC119-01 (hUC-MSCs)<br>for the treatment of<br>Bronchopulmonary Dysplasia.
<br>

<br>

<a href=”http://www.compbio.com/wp-content/uploads/2018/02/cbi-Bronchopulmonary.Dysplasia.pdf” class=”button”>VIEW NOW</a>
<img alt=”” src=”http://www.compbio.com/wp-content/uploads/2018/02/redline.png”>
</div>
</div>